Business Description
Sotac Pharmaceuticals Ltd
ISIN : INE0O2D01012
Share Class Description:
NSE:SOTAC: Ordinary SharesCompare
Compare
Traded in other countries / regions
SOTAC.India IPO Date
2023-04-13Description
Sotac Pharmaceuticals Ltd is a pharma manufacturer, specializing in the manufacturing of a wide range of pharmaceutical products such as Non-Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non-Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray, and cream.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.59 | |||||
| Debt-to-EBITDA | 3.06 | |||||
| Interest Coverage | 3.2 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.27 | |||||
| Beneish M-Score | -0.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.9 | |||||
| 3-Year EBITDA Growth Rate | 78.2 | |||||
| 3-Year FCF Growth Rate | -114.3 | |||||
| 3-Year Book Growth Rate | 162.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.14 | |||||
| 9-Day RSI | 32.43 | |||||
| 14-Day RSI | 34.21 | |||||
| 6-1 Month Momentum % | 2.94 | |||||
| 12-1 Month Momentum % | 2.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.12 | |||||
| Quick Ratio | 0.81 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 75.4 | |||||
| Days Sales Outstanding | 95.02 | |||||
| Days Payable | 132.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -4.05 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 20.75 | |||||
| Operating Margin % | 5.06 | |||||
| Net Margin % | 4.26 | |||||
| FCF Margin % | -32.36 | |||||
| ROE % | 9.9 | |||||
| ROA % | 4.18 | |||||
| ROIC % | 6.86 | |||||
| ROC (Joel Greenblatt) % | 9.34 | |||||
| ROCE % | 9.93 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.1 | |||||
| PE Ratio without NRI | 27.23 | |||||
| PS Ratio | 1.15 | |||||
| PB Ratio | 2.58 | |||||
| Price-to-Tangible-Book | 2.69 | |||||
| EV-to-EBIT | 25.58 | |||||
| EV-to-EBITDA | 16.63 | |||||
| EV-to-Revenue | 1.46 | |||||
| EV-to-FCF | -4.38 | |||||
| Price-to-Graham-Number | 1.8 | |||||
| Earnings Yield (Greenblatt) % | 3.91 | |||||
| FCF Yield % | -28.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sotac Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,047.839 | ||
| EPS (TTM) (₹) | 4.04 | ||
| Beta | 0 | ||
| Volatility % | 46.45 | ||
| 14-Day RSI | 34.21 | ||
| 14-Day ATR (₹) | 2.06354 | ||
| 20-Day SMA (₹) | 111.625 | ||
| 12-1 Month Momentum % | 2.04 | ||
| 52-Week Range (₹) | 87.1 - 202.8 | ||
| Shares Outstanding (Mil) | 11.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sotac Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sotac Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sotac Pharmaceuticals Ltd Frequently Asked Questions
What is Sotac Pharmaceuticals Ltd(NSE:SOTAC)'s stock price today?
The current price of NSE:SOTAC is ₹109.50. The 52 week high of NSE:SOTAC is ₹202.80 and 52 week low is ₹87.10.
When is next earnings date of Sotac Pharmaceuticals Ltd(NSE:SOTAC)?
The next earnings date of Sotac Pharmaceuticals Ltd(NSE:SOTAC) is .
Does Sotac Pharmaceuticals Ltd(NSE:SOTAC) pay dividends? If so, how much?
Sotac Pharmaceuticals Ltd(NSE:SOTAC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers